Thursday 9/5 Insider Buying Report: YEXT, VTVT (Nasdaq.com)
At Yext, a filing with the SEC revealed that on Tuesday, Director Michael Walrath bought 85,429 shares of YEXT, at a cost of $16.42 each, for a total investment of $1.40M. So far Walrath is in the green, up about 5.0% on their buy based on today’s trading high of $17.24. Yext is trading up about 3.5% on the day Thursday. Before this latest buy, Walrath purchased YEXT at 2 other times during the past twelve months, for a total investment of $2.33M at an average of $14.15 per share. And on Wednesday, Ronald O. Perelman purchased $1.00M worth of vTv Therapeutics, purchasing 606,061 shares at a cost of $1.65 each. Before this latest buy, Perelman purchased VTVT at 15 other times during the past year, for a total investment of $26.26M at an average of $1.56 per share. vTv Therapeutics is trading up about 7.4% on the day Thursday.
Amgen Inc (NASDAQ: AMGN) Executives are Making Moves with Their Shares (Analyst Ratings)
Yesterday, the SVP & CCO of Amgen Inc (AMGN), Cynthia Patton, sold shares of AMGN for $1.79M. The company has a one-year high of $211.90 and a one-year low of $166.30. The Company has a Price to Book ratio of 11.5087. AMGN’s market cap is $123.7B and the company has a P/E ratio of 16.33.
Cott Corp (COT) CEO Thomas Harrington Bought $1 million of Shares (Guru Focus)
CEO of Cott Corp, Thomas Harrington, bought 80,000 shares of COT on 09/04/2019 at an average price of $12.56 a share. The total cost of this purchase was $1 million. Cott Corp along with its subsidiaries is engaged in manufacturing and selling beverages. Its is route based service company that offers bottled water and coffee roasting, blending of iced tea and extract solutions for the U.S. foodservice industry. Cott Corp has a market cap of $1.73 billion; its shares were traded at around $12.93 with and P/S ratio of 0.73. The dividend yield of Cott Corp stocks is 1.86%. Cott Corp had annual average EBITDA growth of 9.60% over the past five years. GuruFocus has detected 3 severe warning signs with Cott Corp.
A Director at WillScot Corporation (NASDAQ: WSC) is Selling Shares (Analyst Ratings)
Yesterday, a Director at WillScot Corporation (WSC), Jeffrey Sagansky, sold shares of WSC for $1.4M. Based on WillScot Corporation’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $266 million and GAAP net loss of $10.91 million. In comparison, last year the company earned revenue of $140 million and had a net profit of $236K. The company has a one-year high of $18.19 and a one-year low of $8.21. Currently, WillScot Corporation has an average volume of 549.21K.
Elanco Animal Health Inc (ELAN) President, CEO & Director Jeffrey N Simmons Bought $2 million of Shares (Guru Focus)
President, CEO & Director of Elanco Animal Health Inc, Jeffrey N Simmons, bought 75,750 shares of ELAN on 09/04/2019 at an average price of $26.55 a share. The total cost of this purchase was $2 million. Elanco Animal Health Inc has a market cap of $9.83 billion; its shares were traded at around $26.36 with a P/E ratio of 67.56 and P/S ratio of 3.12. GuruFocus has detected 1 severe warning sign with Elanco Animal Health Inc.
